Related references
Note: Only part of the references are listed.Advanced glycation end products enhance M1 macrophage polarization by activating the MAPK pathway
Sunyue He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
IL-35 promotes microglial M2 polarization in a rat model of diabetic neuropathic pain
Yinghai Jiang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Contribution of FP receptors in M1 macrophage polarization via IL-10-regulated nuclear translocation of NF-κB p65
Toko Maehara et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Psoriasis-Like Inflammation Induced Renal Dysfunction through the TLR/NF-κB Signal Pathway
Fang Ren et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype
Zhuoya Zhang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease
Laura Boi et al.
MOVEMENT DISORDERS (2019)
Macrophage phenotype and its relationship with renal function in human diabetic nephropathy
Xiaoliang Zhang et al.
PLOS ONE (2019)
Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage
Jiandong Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Nicotine instigates podocyte injury via NLRP3 inflammasomes activation
Gurinder Bir Singh et al.
AGING-US (2019)
Thalidomide decreases high glucose-induced extracellular matrix protein synthesis in mesangial cells via the AMPK pathway
Hong-Xia Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Role of the Immune System in Diabetic Kidney Disease
Fionnuala B. Hickey et al.
CURRENT DIABETES REPORTS (2018)
MIF/CD74 axis is a target for metformin therapy in diabetic podocytopathy - real world evidence
Yan Xing et al.
ENDOKRYNOLOGIA POLSKA (2018)
Management of major organ involvement of Behcet's syndrome: a systematic review for update of the EULAR recommendations
Yesim Ozguler et al.
RHEUMATOLOGY (2018)
Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway
Hogxia Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
Meletios A. Dimopoulos et al.
HAEMATOLOGICA (2018)
Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury
Yue Zhou et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Meletios A. Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease
Boris Decourt et al.
CURRENT ALZHEIMER RESEARCH (2017)
Systematic Literature Review and Network Meta-Analysis of Treatment Outcomes in Relapsed and/or Refractory Multiple Myeloma
Chrissy H. Y. van Beurden-Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors
Allah Nawaz et al.
NATURE COMMUNICATIONS (2017)
Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy
Haoran Dai et al.
JOURNAL OF DIABETES RESEARCH (2017)
Role of Immune Cells in Diabetic Kidney Disease
Xiaoqian Yang et al.
CURRENT GENE THERAPY (2017)
Mitophagy regulates macrophage phenotype in diabetic nephropathy rats
Yu Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats
X-M. Qi et al.
INFLAMMATION RESEARCH (2016)
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
Carolina Cunha et al.
MEDIATORS OF INFLAMMATION (2016)
Thalidomide for inflammatory bowel disease Systematic review
Matteo Bramuzzo et al.
MEDICINE (2016)
Trends in Chronic Kidney Disease in China
Luxia Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis
Tzu-Hao Li et al.
SCIENTIFIC REPORTS (2016)
Enhanced M1 and Impaired M2 Macrophage Polarization and Reduced Mitochondria! Biogenesis via Inhibition of AMP Kinase in Chronic Kidney Disease
Cong Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Effects of Shengjiang (Zingiberis Rhizoma Recens) and Its Processed Products on Nitric Oxide Production in Macrophage RAW 264.7 Cells
Hui Liao
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Review of thalidomide use in the pediatric population
Catherine S. Yang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury
Alaa S. Awad et al.
KIDNEY INTERNATIONAL (2015)
1,25-Dihydroxyvitamin D-3 Promotes High Glucose-Induced M1 Macrophage Switching to M2 via the VDR-PPAR gamma Signaling Pathway
Xiaoliang Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Vitamin D Prevents Podocyte Injury via Regulation of Macrophage M1/M2 Phenotype in Diabetic Nephropathy Rats
Xiao-Liang Zhang et al.
ENDOCRINOLOGY (2014)
How Thalidomide Works Against Cancer
A. Keith Stewart
SCIENCE (2014)
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
Waqas Rehman et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2011)
Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases
Yohei Ikezumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Thalidomide and pentoxifylline block the renal effects of supernatants of macrophages activated with Crotalus durissus cascavella venom
AMC Martins et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients
S Bastuji-Garin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Phase II trial of thalidomide in renal-cell carcinoma
B Escudier et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
